{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:41:07Z","timestamp":1791906067329,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324122006017"],"award-info":[{"award-number":["JCYJ20210324122006017"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270069"],"award-info":[{"award-number":["82270069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370073"],"award-info":[{"award-number":["82370073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.116029","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T19:38:28Z","timestamp":1766000308000},"page":"116029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Remdesivir alleviates inflammation and tissue damage in experimental colitis via AnxA5 Signaling"],"prefix":"10.1016","volume":"169","author":[{"given":"Hailong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zherui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.116029_bb0005","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1038\/s41467-022-32505-8","article-title":"Mannose ameliorates experimental colitis by protecting intestinal barrier integrity","volume":"13","author":"Dong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.116029_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5217\/ir.2016.14.4.322","article-title":"Surgical management of inflammatory bowel disease in China: a systematic review of two decades","volume":"14","author":"Yu","year":"2016","journal-title":"Intest Res"},{"key":"10.1016\/j.intimp.2025.116029_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.116029_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","article-title":"Ulcerative colitis and Crohn\u2019s disease have similar burden and goals for treatment","volume":"18","author":"Le Berre","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.116029_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14309\/ajg.0000000000002485","article-title":"A review of available medical therapies to treat moderate-to-severe inflammatory bowel disease","volume":"119","author":"Chang","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.116029_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja17.01001","article-title":"Management of inflammatory bowel disease","volume":"209","author":"Wright","year":"2018","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.intimp.2025.116029_bb0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-019-0268-7","article-title":"Host-microbiota interactions in inflammatory bowel disease","volume":"20","author":"Caruso","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.116029_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41419-021-03843-0","article-title":"Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-\u03baB signaling","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.116029_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41575-020-00399-w","article-title":"The intestinal barrier, an arbitrator turned provocateur in IBD","volume":"18","author":"Mehandru","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.116029_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02201-4","article-title":"Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPAR\u03b1-CYP4X1 axis in colonic macrophages","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.116029_bb0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2020.10.259","article-title":"Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota","volume":"166","author":"Cui","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2025.116029_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41575-023-00766-3","article-title":"Paracellular permeability and tight junction regulation in gut health and disease","volume":"20","author":"Horowitz","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.116029_bb0065","doi-asserted-by":"crossref","first-page":"R1135","DOI":"10.1016\/j.cub.2023.09.027","article-title":"Tight junctions","volume":"33","author":"Balda","year":"2023","journal-title":"Curr. Biol."},{"key":"10.1016\/j.intimp.2025.116029_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106368","article-title":"Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in ulcerative colitis through tight junction proteins degradation and epithelium apoptosis","volume":"183","author":"Li","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.116029_bb0075","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.apsb.2021.09.007","article-title":"Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK\/FOXO3a\/BIM-dependent manner","volume":"12","author":"Zheng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.116029_bb0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41467-020-14821-z","article-title":"Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.116029_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215857","article-title":"Annexin A5 as a targeting agent for cancer treatment","volume":"547","author":"Woodward","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.116029_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph16060837","article-title":"Annexin A5 inhibits endothelial inflammation induced by lipopolysaccharide-activated platelets and microvesicles via phosphatidylserine binding","volume":"16","author":"Tschirhart","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.intimp.2025.116029_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-021-00626-z","article-title":"Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.116029_bb0100","first-page":"11","article-title":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2025.116029_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01814-20","article-title":"New perspectives on antimicrobial agents: remdesivir treatment for COVID-19","volume":"65","author":"Aleissa","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2025.116029_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652446","article-title":"Remdesivir alleviates acute kidney injury by inhibiting the activation of NLRP3 inflammasome","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116029_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.24272\/j.issn.2095-8137.2021.469","article-title":"Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice","volume":"43","author":"Wu","year":"2022","journal-title":"Zool. Res."},{"key":"10.1016\/j.intimp.2025.116029_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112465","article-title":"Remdesivir ameliorates ulcerative colitis-propelled cell inflammation and pyroptosis in acetic acid rats by restoring SIRT6\/FoxC1 pathway","volume":"137","author":"Oraby","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.116029_bb0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41401-021-00726-0","article-title":"Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1\/Sirt1 axis","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.116029_bb0130","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/aps.2017.185","article-title":"Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages","volume":"39","author":"Yan","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.116029_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2020.7890","article-title":"TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2","volume":"45","author":"Guo","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2025.116029_bb0140","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.116029_bb0145","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2025.116029_bb0150","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.2147\/JIR.S529493","article-title":"Intestinal microbiota dysbiosis disrupts the mucosal barrier, triggering inflammatory responses in gut-kidney interaction and exacerbating Diarrhea","volume":"18","author":"Shen","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.116029_bb0155","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2025.116029_bb0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116029_bb0165","article-title":"Remdesivir for the treatment of COVID-19","author":"Grundeis","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2025.116029_bb0170","first-page":"9","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.116029_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and other viral diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2025.116029_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2020.03.034","article-title":"Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING","volume":"526","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.116029_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114037","article-title":"Remdesivir inhibits the progression of glioblastoma by enhancing endoplasmic reticulum stress","volume":"157","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.116029_bb0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"IL-12 and IL-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.116029_bb0195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jpha.2022.08.001","article-title":"Rabdosia Serra alleviates dextran sulfate sodium salt-induced colitis in mice through anti-inflammation, regulating Th17\/Treg balance, maintaining intestinal barrier integrity, and modulating gut microbiota","volume":"12","author":"Li","year":"2022","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.intimp.2025.116029_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"Antoni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.116029_bb0205","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.mucimm.2023.06.004","article-title":"Sialylation shapes mucus architecture inhibiting bacterial invasion in the colon","volume":"16","author":"Taniguchi","year":"2023","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2025.116029_bb0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: from simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116029_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\u2019s disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2025.116029_bb0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41401-022-00933-3","article-title":"Hederacoside C ameliorates colitis via restoring impaired intestinal barrier through moderating S100A9\/MAPK and neutrophil recruitment inactivation","volume":"44","author":"Zha","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.116029_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109532","article-title":"Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1\/AKT\/NF-\u03baB signaling pathway","volume":"114","author":"Yao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.116029_bb0230","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1038\/s41467-023-38840-8","article-title":"Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis","volume":"14","author":"Gui","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.116029_bb0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.116029_bb0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaut.2008.04.012","article-title":"Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity","volume":"31","author":"Pai","year":"2008","journal-title":"J. Autoimmun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:58:06Z","timestamp":1771520286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"alternative-id":["S1567576925020181"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116029","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remdesivir alleviates inflammation and tissue damage in experimental colitis via AnxA5 Signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116029"}}